Andre Goy, MD, from John Theurer Cancer Center, discusses recent research into fighting cancer with the immune system.
Andre Goy, MD, Chairman and Director and Chief of Lymphoma at John Theurer Cancer Center, discusses recent research into fighting cancer with the immune system.
The effort to harness the immune system to fight cancers cells has had some success, though little that translate into lasting benefit for a patient. More recently, the development of immunology has focused on unleashing T cells and promoting their antitumor effect.
Immunology research has focused, among other things, on generating chimeric antigen T cells and developing monoclonal antibodies to unleash T cells.
The oncology community, Goy says, believes that using the immune system seems promising and could translate into enormous benefit for patients.
Response Time and BRAF Status Factor Into IO Selection for Melanoma
January 29th 2025During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed how data from the CheckMate-067 and RELATIVITY-047 affect their choice of therapy for metastatic melanoma in the first article of a 2-part series.
Read More
Fedratinib Shows Promise in Chronic Neutrophilic Leukemia and MDS/MPN
January 20th 2025In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with myelodysplastic syndrome/myeloproliferative neoplasms and chronic neutrophilic leukemia.
Read More